FUMAGALLI, LAURA
 Distribuzione geografica
Continente #
EU - Europa 7.509
NA - Nord America 6.521
AS - Asia 5.917
SA - Sud America 499
AF - Africa 212
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.696
Nazione #
US - Stati Uniti d'America 6.296
IT - Italia 1.969
GB - Regno Unito 1.916
CN - Cina 1.758
SG - Singapore 1.621
DE - Germania 1.037
SE - Svezia 571
HK - Hong Kong 541
RU - Federazione Russa 457
BD - Bangladesh 445
FR - Francia 439
IN - India 373
BR - Brasile 345
VN - Vietnam 332
NL - Olanda 237
KR - Corea 200
TR - Turchia 172
IE - Irlanda 158
UA - Ucraina 149
FI - Finlandia 141
CA - Canada 137
DK - Danimarca 119
ID - Indonesia 95
JP - Giappone 92
EG - Egitto 63
EU - Europa 62
ES - Italia 54
PH - Filippine 49
PL - Polonia 49
CI - Costa d'Avorio 47
MX - Messico 47
AR - Argentina 44
TW - Taiwan 41
CO - Colombia 40
BE - Belgio 37
CH - Svizzera 36
AT - Austria 30
AU - Australia 27
ZA - Sudafrica 25
GR - Grecia 24
IQ - Iraq 24
PK - Pakistan 23
DZ - Algeria 20
EC - Ecuador 19
IL - Israele 19
CL - Cile 18
MY - Malesia 18
VE - Venezuela 16
UZ - Uzbekistan 15
NG - Nigeria 14
SA - Arabia Saudita 14
JO - Giordania 13
PT - Portogallo 12
RO - Romania 12
IR - Iran 11
TN - Tunisia 10
MA - Marocco 9
PY - Paraguay 9
TH - Thailandia 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
NO - Norvegia 8
KE - Kenya 7
KZ - Kazakistan 7
SC - Seychelles 7
SK - Slovacchia (Repubblica Slovacca) 7
BG - Bulgaria 5
CR - Costa Rica 5
GT - Guatemala 5
MK - Macedonia 5
RS - Serbia 5
AL - Albania 4
AZ - Azerbaigian 4
BO - Bolivia 4
KW - Kuwait 4
LT - Lituania 4
NZ - Nuova Zelanda 4
AM - Armenia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
KH - Cambogia 3
NP - Nepal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BZ - Belize 2
CM - Camerun 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
Totale 20.720
Città #
Southend 1.672
Singapore 955
Ashburn 731
Milan 656
Chandler 509
Hong Kong 489
San Jose 372
Beijing 366
Santa Clara 291
Dallas 281
Hanover 266
Council Bluffs 229
Ann Arbor 212
Los Angeles 183
Princeton 183
Seattle 164
Wilmington 164
Dublin 154
Fairfield 151
Mountain View 118
Dearborn 116
Boardman 114
New York 108
Buffalo 104
Ho Chi Minh City 103
Woodbridge 102
Seoul 99
Chicago 96
Munich 96
Rome 95
Bengaluru 94
Hanoi 92
Hefei 91
Lauterbourg 91
Nanjing 83
Jacksonville 80
Guangzhou 79
Houston 79
Frankfurt am Main 78
Des Moines 73
Toronto 69
Shanghai 67
Redmond 66
The Dalles 64
Tokyo 61
Jakarta 58
Moscow 57
Cambridge 56
Helsinki 56
Phoenix 56
Redwood City 56
Abidjan 46
Columbus 46
Istanbul 44
Andover 41
Cairo 39
Shenyang 38
Changsha 37
Berlin 36
Atlanta 35
Sakarya 35
Petina 34
Salt Lake City 34
Serra 34
Somerville 34
Bogotá 33
Nanchang 33
São Paulo 33
Bühl 31
Jinan 31
Naples 31
Brussels 30
Turin 30
Mumbai 29
Fuzhou 26
Tianjin 26
Cangzhou 24
Hangzhou 24
Hebei 23
Kiez 23
London 23
Medford 23
Bologna 22
Monza 22
Grafing 21
Amsterdam 20
Nürnberg 20
Athens 19
Catania 19
Palermo 19
Zhengzhou 19
Orem 18
San Diego 18
Shenzhen 18
Sunnyvale 18
Dong Ket 17
Düsseldorf 17
Elk Grove Village 17
Nuremberg 17
Washington 17
Totale 12.029
Nome #
Synthesis and alpha4beta2 nicotinic affinity of 2-pyrrolidinylmethoxyimines and prolinal oxime ethers 568
Unraveling the parahormetic mechanism underlying the health-protecting effects of grapeseed procyanidins 483
ANALOGHI STRUTTURALI DEL WB 4101: PROGETTAZIONE, SINTESI E VALUTAZIONE BIOLOGICA 475
A selective alpha1D-adrenoreceptor antagonist inhibits human prostate cancer cell proliferation and motility "in vitro" 421
Behavioural and pharmacological characterization of a novel cannabinomimetic adamantane-derived indole, APICA, and considerations on the possible misuse as a psychotropic spice abuse, in C57bl/6J mice 362
The VEGA suite of programs: a versatile platform for cheminformatics and drug design projects 362
Sintesi “Green” di un nuovo agente antimicrobico 334
Development of a direct ESI-MS method for measuring the tannin precipitation effect of proline-rich peptides and in silico studies on the proline role in tannin-protein interactions 330
Profiling Vaccinium macrocarpon components and metabolites in human urine and the urine ex-vivo effect on Candida albicans adhesion and biofilm-formation 326
Compounds having preservative, antimicrobial and antiseptic activity 317
Utilization of diverse organophosphorus pollutants by marine bacteria 312
Chemistry and pharmacology of a series of unichiral analogues of 2-(2-pyrrolidinyl)-1,4-benzodioxane, prolinol phenyl ether and prolinol 3-pyridyl ether designed as alpha4beta2-nicotinic acetylcholine receptor agonists 311
Benzodioxane–benzamides as new bacterial cell division inhibitors 307
Structure–affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of α1 antagonist WB-4101 305
Unexpected activity of bromiphen against prokaryotic and eukaryotic infectious agents 295
Resolution of 5-hydroxymethyl-2-oxazolidinone by preferential crystallization[ 1 ] and investigations on the nature of the racemates of some 2-oxazolidinone derivatives 292
3-(Benzodioxan-2-ylmethoxy)-2,6-difluorobenzamides bearing hydrophobic substituents at the 7-position of the benzodioxane nucleus potently inhibit methicillin-resistant Sa and Mtb cell division 291
QSAR study for a novel series of ortho monosubstituted phenoxy analogues of alpha(1)-adrenoceptor antagonist WB4101 289
Novel potential multitarget compounds for treatment of Type 2 Diabetes 289
(Z)-5-(3′,4′-Bis(benzyloxy)benzylidene)furan-2(5H)-one 280
Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective α1B-adrenoceptor antagonist 274
Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs 268
Analytical Profile and Antioxidant and Anti-Inflammatory Activities of the Enriched Polyphenol Fractions Isolated from Bergamot Fruit and Leave 261
Processo di risoluzione di 2-ossazolidinoni racemici 251
ANALOGUES OF ALPHA1-ADRENOCEPTOR ANTAGONIST WB4101: DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION 248
Characterization of in vitro metabolites of JWH-018, JWH-073 and their 4-methyl derivatives, markers of the abuse of these synthetic cannabinoids 247
Univocal syntheses of 2- and 3-hydroxymethyl-2,3-dihydro[1,4]dioxino[2,3-b]pyridine enantiomers 245
A short entry to enantiopure 2-substituted 1,4-benzodioxanes by efficient resolution methods 244
Cyclo(His-Pro) Exerts Protective Carbonyl Quenching Effects through Its Open Histidine Containing Dipeptides 243
QSAR study for a novel series of ortho disubstituted phenoxy analogues of a1-adrenoceptor antagonist WB4101 241
Processo di risoluzione di un sale della carnitinammide 237
Highly efficient resolutions of 1,4-benzodioxane-2-carboxylic acid with para substituted 1-phenylethylamines 235
COMPOUNDS HAVING PRESERVATIVE, ANTIMICROBIAL AND ANTISEPTIC ACTIVITY 233
Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase 230
Data on thermal and hydrolytic stability of both domiphen bromide and para-bromodomiphen bromide 228
Back to basics : choosing the appropriate surface disinfectant 226
From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at alpha4beta2 nicotinic acetylcholine receptor 224
Synthesis and a4b2 nicotinic affinity of the stereoisomers of 2-(1-methyl-2-pyrrolidinyl)-1,4-benzodioxane and of its nor-methyl derivative 223
Repositioning dequalinium as potent muscarinic allosteric ligand by combining virtual screening campaigns and experimental binding assays 223
SYNTHESIS AND BINDING AFFINITY OF NEW HIGHLY SELECTIVE alpha4beta2 NICOTINIC LIGANDS 221
Heteroaryl carnosine analogues: design, synthesis and carbonyl quenching activity 220
Unexpected reactivity of the antiseptic domiphen bromide 218
SYNTHESIS AND BINDING AFFINITY OF NEW HIGHLY SELECTIVE alpha4beta2 NICOTINIC LIGANDS 217
Unichiral 2-(2′-Pyrrolidinyl)-1,4-benzodioxanes : the 2R,2′S Diastereomer of the N-Methyl-7-hydroxy Analogue Is a Potent α4β2- and α6β2-Nicotinic Acetylcholine Receptor Partial Agonist 216
Diadenosine tetraphosphate (Ap4A) - an E. coli alarmone or a damage metabolite? 216
How do reaction conditions affect the enantiopure synthesis of 2-substituted-1,4-benzodioxane derivatives? 216
Activation Effects of Carnosine- and Histidine-Containing Dipeptides on Human Carbonic Anhydrases: A Comprehensive Study 215
Analisi farmaceutica 215
SEARCH FOR SELECTIVE ANTAGONISTS AT α1-ADRENORECEPTOR SUBTYPES: WB-4101 RELATED COMPOUNDS 213
6‑Methoxy-7-benzofuranoxy and 6‑Methoxy-7-indolyloxy Analogues of 2‑[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4- benzodioxane (WB4101) : 1 Discovery of a Potent and Selective α1D Adrenoceptor Antagonist 211
Farnesyltransferase inhibitors : CAAX mimetics based on different biaryl scaffolds 210
Synthesis and alpha 4 beta 2 nicotinic affinity of unichiral 5-(2-pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes 209
Novel potential DPP IV/CA II inhibitors for treatment of type 2 diabetes 208
Structure Activity Relationship of novel antimicrobial agents, acting as inhibitors of the bacterial cell division protein Ftsz 207
The use of the naphthyl probe to scan the alpha-1A/5HT1A receptor binding sites: discovery of novel alpha-1A selective antagonists 206
Design, synthesis and binding affinity of acetylcholine carbamoyl analogues 205
WB4101-related compounds: New, subtype-selective alpha(1)-adrenoreceptor antagonists (or inverse agonists?) 204
Development and validation of a HPLC method for the direct separation of carnosine enantiomers and analogues in dietary supplements 203
Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options 201
Evaluation of in vitro SARS-CoV-2 inactivation by a new quaternary ammonium compound: Bromiphen bromide 201
Simple process for the preparation of cetyltrimethylammonium naproxenate (naprocet) 197
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NON-PEPTIDIC INHIBITORS OF FARNEYLTRANSFRERASE 195
Diastereomeric 2-aminomethyl-1,4-benzodioxane mandelates : phase diagrams and resolution 192
Discovery of a potent and highly selective Dipeptidyl Peptidase IV and Carbonic Anhydrase inhibitor as “antidiabesity” agent based on repurposing and morphing of WB-4101 190
A highly efficient method for the alpha,beta-dehydrogenation of alpha-amino esters and alpha-amino-beta-diesters 189
Stressed degradation studies of domiphen bromide by LC-ESI-MS/MS identify a novel promising antimicrobial agent 189
Entrainment resolution of carnitinamide chloride 188
Detection and quantification of several synthetic cannabinoids in human plasma by chromatography-mass specrtometry using two new non deuterated internal standards 186
Candida albicans Biofilm Inhibition by Two Vaccinium macrocarpon (Cranberry) Urinary Metabolites: 5-(3',4'-{DihydroxyPhenyl})-gamma-Valerolactone and 4-Hydroxybenzoic Acid 183
Vaccinium macrocarpon urine metabolites identification, quantification and evaluation of their effect on Candida albicans adhesion 182
Analytical, computational and formulation studies on TPGS as P-gp inhibitor 178
A Novel Chromatographic Method to Assess the Binding Ability towards Dicarbonyls 175
Novel inhibitors of the bacterial cell division protein FtsZ: synthesis and antibacterial activity 173
Novel 5-substituted 3-hydroxyphenyl and 3-nitrophenyl ethers of S-prolinol as α4β2-nicotinic acetylcholine receptor ligands 170
Resolution of 2-substituted 1,4-benzodioxanes by entrainment 168
Concise synthesis of deuterium-labelled proanthocyanidin metabolite 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone as an analytical tool 167
Modelling of full-length human α4β2 nicotinic receptor by fragmental approach and analysis of its binding modes 165
Chemoenzymatic approach towards the synthesis of the antitumor and antileishmanial marine metabolite (+)-Harzialactone A via the stereoselective, biocatalyzed reduction of a prochiral ketone 164
Enantiomerically Pure Dibenzyl Esters of L‑Aspartic and L‑Glutamic Acid 163
One-pot racemization process of 1-phenyl-1,2,3,4-tetrahydroisoquinoline : a key intermediate for the antimuscarinic agent solifenacin 160
Exploring Secondary Amine Carnosine Derivatives: Design, Synthesis, and Properties 158
Highly efficient racemisation of a key intermediate of the antibiotic moxifloxacin 148
Predicting the physicochemical profile of diastereoisomeric histidine-containing dipeptides by property space analysis 147
Enantiomer systems of carnitinamide inorganic salts: introductory studies to a successful entrainment resolution 146
Crystallization-based resolution of 1,4-benzodioxane-2-carboxylic acid enantiomers via diastereomeric 1-phenylethylamides 146
Stable isotopic labelling of β-sitosteryl ferulate for use as analytical tool 144
Direct HPLC separation of carnosine enantiomers with two chiral stationary phases based on penicillamine and teicoplanin derivatives 143
Peptidomimetic inhibitors of farnesyltransferase with high in vitro activity and significant cellular potency 141
From carnitinamide to 5-aminomethyl-2-oxazolidinones 138
HETEROARYLOXY ANALOGUES OF WB4101: SYNTHESIS AND BIOLOGICAL EVALUATION AT ALPHA-1-ADRENOCEPTOR SUBTYPES 125
Regioselective, Efficient and Sustainable Bromination Process for the Synthesis of the Antimicrobial Agent Bromiphen Bromide 122
New Ras CAAX mimetics : design, synthesis, antiproliferative activity, and RAS prenylation inhibition 109
Quinone Methide-Based Organophosphate Hydrolases Inhibitors : Trans Proximity Labelers versus Cis Labeling Activity-Based Probes 105
Highly efficient resolutions with isopropylidene glycerol 3-carboxy-2-naphthoate 104
5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: Synthesis of all the stereoisomers and α4β2 nicotinic affinity 91
Benzyl-N-[4-(2-hydroxyethyl)-1,3-thiazol-2-yl]carbamate 72
A Mild and Rapid Method for the Preparation of 2,6-Dimethoxycyclohexa-2,5-diene-1,4-dione 63
PepScorer::RMSD: an improved machine learning scoring function for protein–peptide docking 40
null 10
null 2
Totale 21.690
Categoria #
all - tutte 57.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.799


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 0 119
2021/20221.791 151 84 55 78 169 132 332 97 163 94 134 302
2022/20231.825 254 225 197 198 165 293 51 122 155 51 63 51
2023/20241.442 53 99 96 94 259 134 111 113 75 101 111 196
2024/20253.245 128 243 63 284 272 153 113 320 194 284 317 874
2025/20266.562 659 470 605 468 555 403 737 316 621 531 747 450
Totale 21.690